Houston Methodist

Targeting Adaptive Immune System in Alzheimer's Disease

Recent findings, including the discovery of risk genes involved in inflammation signaling, indicate that inflammation is critical for the onset and progression of Alzheimer's Disease. Regulatory T cells (Tregs) play an important neuroprotective role in suppressing microglia/macrophage-mediated inflammation, as well as modulating adaptive immune reactions. A progressive compromise in the immunomeulatory function of Tregs occurs through the course of Alzheimer's disease. Recovering the immunosuppressive capacity of Tregs may serve as a potential immunotherapy to treat Alzheimer's pathology.

Alireza Faridar, MD
Neurologist
Stanley H. Appel Department of Neurology
Nantz National Alzheimer Center
Houston Methodist

This event will be held in the Ernest H. Cockrell Boardroom (R211-311) & Online via MS Teams. In-person attendance is limited.

Dial-In Information

Join Microsoft Teams Meeting

+1 832-856-3689 United States, Houston (Toll)

Conference ID: 250 483 625#

Tuesday, October 6 at 2:00pm to 3:00pm

Virtual Event
Event Type

Seminar, Webinar

Attendance Options

In-Person, Livestream Video

Category

Research

Department & Center
Department of Neurology, Nantz National Alzheimer Center, Academic Institute
Speaker

Alireza Faridar, MD, Neurologist, Stanley H. Appel Department of Neurology, Nantz National Alzheimer Center, Houston Methodist

Contact Email

cherrera2@houstonmethodist.org

Subscribe
Google Calendar iCal Outlook